1-17 of 17
Catherine M. Bollard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease

Clinical Trials & Observations
Tami D. John, Mark C. Walters, Hemalatha G. Rangarajan, Mahvish Q. Rahim, Christopher McKinney, Catherine M. Bollard, Ghada Abusin, Mary Eapen, Adetola A. Kassim, Michael R. DeBaun
Journal: Blood Advances
Blood Adv (2024) 8 (23): 6055–6063.
https://doi.org/10.1182/bloodadvances.2024014078
Published: 2024
Includes: Supplemental data
Journal Articles

Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study

Clinical Trials & Observations
Birte Wistinghausen, Keri Toner, Donald A. Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela Chansky, Gloria Pezzella, Lauren Saguilig, Robert J. Hayashi, Harshal Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick Hanley, Michelle L. Hermiston, Carl E. Allen, Catherine M. Bollard
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1116–1127.
https://doi.org/10.1182/bloodadvances.2023010832
Published: 2024
Includes: Supplemental data
Journal Articles

Celebrating a year of cancer research in Blood Advances

Catherine M. Bollard, Andrew Weyrich
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7621–7623.
https://doi.org/10.1182/bloodadvances.2023011867
Published: 2023
Journal Articles

Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT

Ashley V. Geerlinks, Brooks Scull, Christa Krupski, Ryan Fleischmann, Michael A. Pulsipher, Mary Eapen, James A. Connelly, Catherine M. Bollard, Sung-Yun Pai, Christine N. Duncan, Leslie S. Kean, K. Scott Baker, Lauri M. Burroughs, Jeffrey R. Andolina, Shalini Shenoy, Philip Roehrs, Rabi Hanna, Julie-An Talano, Kirk R. Schultz, Elizabeth O. Stenger, Howard Lin, Adi Zoref-Lorenz, Kenneth L. McClain, Michael B. Jordan, Tsz-Kwong Man, Carl E. Allen, Rebecca A. Marsh
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3725–3734.
https://doi.org/10.1182/bloodadvances.2022009478
Published: 2023
Includes: Supplemental data
Journal Articles

Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease

Clinical Trials & Observations
Hannah Kinoshita, Mamatha Mandava, Mariah Jensen-Wachspress, Haili Lang, Elisabeth Joy, Jay Tanna, Chase D. McCann, Samuel O’Brien, Sianna Burnett, Abeer Shibli, Fahmida Hoq, Monica Bhatia, Patrick J. Hanley, Blachy Dávila Saldaña, Kris M. Mahadeo, Catherine M. Bollard, Michael D. Keller, Allistair Abraham
Journal: Blood Advances
Blood Adv (2023) 7 (10): 2105–2116.
https://doi.org/10.1182/bloodadvances.2022008219
Published: 2023
Includes: Supplemental data
Journal Articles

Celebrating a year of clinical and translational research in Blood Advances

Catherine M. Bollard, Andrew Weyrich
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6271–6273.
https://doi.org/10.1182/bloodadvances.2022009151
Published: 2022
Journal Articles

Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant

Jeremy D. Rubinstein, Carolyn Lutzko, Thomas Leemhuis, Xiang Zhu, Giang Pham, Lorraine Ray, Shawn Thomas, Celeste Dourson, Jamie Wilhelm, Adam Lane, Jose A. Cancelas, Dakota Lipps, Justin Ferrell, Patrick J. Hanley, Michael D. Keller, Catherine M. Bollard, YunZu M. Wang, Stella M. Davies, Adam S. Nelson, Michael S. Grimley
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2897–2907.
https://doi.org/10.1182/bloodadvances.2021006309
Published: 2022
Journal Articles

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT

Clinical Trials & Observations
Hannah Kinoshita, Kenneth R. Cooke, Melanie Grant, Maja Stanojevic, C. Russell Cruz, Michael Keller, Maria Fernanda Fortiz, Fahmida Hoq, Haili Lang, A. John Barrett, Hua Liang, Jay Tanna, Nan Zhang, Abeer Shibli, Anushree Datar, Kenneth Fulton, Divyesh Kukadiya, Anqing Zhang, Kirsten M. Williams, Hema Dave, Jeffrey S. Dome, David Jacobsohn, Patrick J. Hanley, Richard J. Jones, Catherine M. Bollard
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2520–2534.
https://doi.org/10.1182/bloodadvances.2021006831
Published: 2022
Includes: Supplemental data
Journal Articles

A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation

Clinical Trials & Observations
Courtney M. Rowan, Lincoln Smith, Matthew P. Sharron, Laura Loftis, Sapna Kudchadkar, Christine N. Duncan, Francis Pike, Paul A. Carpenter, David Jacobsohn, Catherine M. Bollard, Conrad Russell Y. Cruz, Abhijeet Malatpure, Sherif Farag, Jamie Renbarger, Morgan R. Little, Phillip R. Gafken, Robert A. Krance, Kenneth R. Cooke, Sophie Paczesny
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1866–1878.
https://doi.org/10.1182/bloodadvances.2021005770
Published: 2022
Includes: Supplemental data
Journal Articles

Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma

Clinical Trials & Observations
Hema Dave, Madeline Terpilowski, Mimi Mai, Keri Toner, Melanie Grant, Maja Stanojevic, Christopher Lazarski, Abeer Shibli, Stephanie A. Bien, Philip Maglo, Fahmida Hoq, Reuven Schore, Martha Glenn, Boyu Hu, Patrick J. Hanley, Richard Ambinder, Catherine M. Bollard
Journal: Blood Advances
Blood Adv (2022) 6 (2): 473–485.
https://doi.org/10.1182/bloodadvances.2021005343
Published: 2022
Includes: Supplemental data
Journal Articles

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia

Clinical Trials & Observations
Blachy J. Dávila Saldaña, Tami John, Challice Bonifant, David Buchbinder, Sharat Chandra, Shanmuganathan Chandrakasan, Weni Chang, Leon Chen, Hannah L. Elfassy, Ashley V. Geerlinks, Roger H. Giller, Rakesh Goyal, David Hagin, Shahidul Islam, Kanwaldeep Mallhi, Holly K. Miller, William Owen, Martha Pacheco, Niraj C. Patel, Christiane Querfeld, Troy Quigg, Nameeta Richard, Deborah Schiff, Evan Shereck, Elizabeth Stenger, Michael B. Jordan, Helen E. Heslop, Catherine M. Bollard, Jeffrey I. Cohen
Journal: Blood Advances
Blood Adv (2022) 6 (2): 452–459.
https://doi.org/10.1182/bloodadvances.2021005291
Published: 2022
Includes: Supplemental data
Journal Articles

Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted

Clinical Trials & Observations
Jeremy D. Rubinstein, Xiang Zhu, Thomas Leemhuis, Giang Pham, Lorraine Ray, Sana Emberesh, Sonata Jodele, Shawn Thomas, Jose A. Cancelas, Catherine M. Bollard, Patrick J. Hanley, Michael D. Keller, Olivia Grimley, Diana Clark, Teri Clark, Cecilia S. Lindestam Arlehamn, Alessandro Sette, Stella M. Davies, Adam S. Nelson, Michael S. Grimley, Carolyn Lutzko
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3309–3321.
https://doi.org/10.1182/bloodadvances.2021004456
Published: 2021
Includes: Supplemental data
Journal Articles

Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma

Clinical Trials & Observations
Xinjie Xu, Christian N. Paxton, Robert J. Hayashi, Kimberly P. Dunsmore, Stuart S. Winter, Stephen P. Hunger, Naomi J. Winick, William L. Carroll, Mignon L. Loh, Meenakshi Devidas, Thomas G. Gross, Catherine M. Bollard, Sherrie L. Perkins, Rodney R. Miles
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2890–2900.
https://doi.org/10.1182/bloodadvances.2021004334
Published: 2021
Includes: Supplemental data
Journal Articles

Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients

Adam S. Nelson, Daria Heyenbruch, Jeremy D. Rubinstein, Anthony Sabulski, Sonata Jodele, Shawn Thomas, Carolyn Lutzko, Xiang Zhu, Thomas Leemhuis, Jose A. Cancelas, Michael Keller, Catherine M. Bollard, Patrick J. Hanley, Stella M. Davies, Michael S. Grimley
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5745–5754.
https://doi.org/10.1182/bloodadvances.2020003073
Published: 2020
Includes: Supplemental data
Journal Articles

Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy

Clinical Trials & Observations
Jeremy D. Rubinstein, Xiang Zhu, Carolyn Lutzko, Tom Leemhuis, Jose A. Cancelas, Sonata Jodele, Catherine M. Bollard, Patrick J. Hanley, Stella M. Davies, Michael S. Grimley, Adam S. Nelson
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3252–3257.
https://doi.org/10.1182/bloodadvances.2020002252
Published: 2020
Journal Articles

Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients

Clinical Trials & Observations
Allistair A. Abraham, Tami D. John, Michael D. Keller, C. Russell Y. Cruz, Baheyeldin Salem, Lauren Roesch, Hao Liu, Fahmida Hoq, Bambi J. Grilley, Adrian P. Gee, Hema Dave, David A. Jacobsohn, Robert A. Krance, Elizabeth. J. Shpall, Caridad A. Martinez, Patrick J. Hanley, Catherine M. Bollard
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2057–2068.
https://doi.org/10.1182/bloodadvances.2019000201
Published: 2019
Includes: Supplemental data
Journal Articles

Developing T-cell therapies for lymphoma without receptor engineering

Melanie Grant, Catherine M. Bollard
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2579–2590.
https://doi.org/10.1182/bloodadvances.2017009886
Published: 2017